UCH-L3 Deubiquitinase Inhibitor Screening Kit

  • Catalog number
    K471-100
  • Price
    Please ask
  • Size
    100 assays
  • Summary
    • Detection method- Fluorescence (RFU= 360/460 nm) • Application-Screening/characterizing/studying UCH-L3 inhibitors/activators
  • Detection Method
    Fluorescence (RFU= 360/460 nm)
  • Applications
    Screening/characterizing/studying UCH-L3 inhibitors/activators
  • Features Benefits
    • Simple and reliable test to screen UCH-L3 inhibitors/activators • High-throughput compatible • Includes Inhibitor Control
  • Storage Conditions
    -20°C
  • Shipping Conditions
    gel pack
  • Shelf life
    12 months
  • Background
    Diseases such as cancer and Alzehimer’s are often the result of dysregulation of proteostasis. Protein levels in the cell are regulated by both synthesis and degradation, with some proteins being marked for either localization or proteasomal degradation through the attachment of ubiquitin, a small, 76-amino acid protein. This attachment, termed ‘ubiquitination,’ or ‘ubiquitylation’ can be reversed by enzymes known as deubiquitinases (DUBs). The human proteome includes as many as four hundred DUBs, and thus these enzymes offer more specific targets for altering cellular equilibrium. UCH-L3, a DUB, is a cysteine protease that has been implicated in prostate cancer, although its regulation and downstream targets are largely unknown. It has been found that UCH-L3 is a novel regulator of epithelial-to-mesenchymal transition in cancer cell metastasis, making it an attractive drug target. Unfortunately, specific inhibitors for this and other DUBs are not readily available. Such compounds would also be a necessity for further illuminating and understanding downstream signaling. BioVision’s UCH-L3 Inhibitor Screening Kit utilizes the ability of active human UCH-L3 deubiquitinase to cleave a synthetic DUB substrate to release a fluorophore, which can be easily quantified (Ex/Em = 360/460 nm) using a fluorescence microplate reader. This inhibitor screening kit thus allows rapid and reliable determination of the inhibitory effects of various compounds on UCH-L3 deubiquitinase and could be used to screen for novel inhibitors. A nonspecific DUB inhibitor is included in this kit to allow the user to validate the experimental setup
  • Additional description
    Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.
  • Gene target
  • Gene symbol
    UCHL3, RPL3, LMO7-AS1, KLK9, UCHL1, MRPL38, CCR6, ADARB1
  • Short name
    UCH-L3 Deubiquitinase Inhibitor Screening Kit
  • Alternative name
    UCH-L3 Deubiquitinase suppressor detection reagent
  • Alternative technique
    kits
  • Alternative to gene target
    v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, C-Kit and CD117 and PBT and SCFR, KIT and IDBG-18980 and ENSG00000157404 and 3815, transferase activity, Extracellular, Kit and IDBG-172083 and ENSMUSG00000005672 and 16590, KIT and IDBG-642326 and ENSBTAG00000002699 and 280832
Gene info
Gene info
Gene info
Gene info
Gene info
Gene info
Gene info
Gene info
Product images
Similar products
Filters
Contact
Chat with gentaur.com employee